AI Act Technical Documentation (Annex IV)
The information set a provider must maintain to demonstrate a high-risk AI system's compliance with Articles 8 to 15.
Definition
Article 11 and Annex IV require providers of high-risk AI systems to prepare and keep up to date technical documentation covering system description, design specification, monitoring and control, risk management, training and testing data (methodology, provenance, labelling, cleaning), validation and testing procedures, cybersecurity, and the post-market monitoring plan.What this means in practice
For medical devices, Annex IV elements fold into the MDR Annex II or IVDR Annex II technical documentation rather than sitting in a separate file. Data-governance evidence (Article 10) is the section most often underdeveloped in existing device technical files.Examples
- A manufacturer developing an AI-powered diagnostic imaging system includes detailed descriptions of its architecture, data sources for training, validation protocols, and cybersecurity safeguards in its technical documentation.
- A provider of an AI system for surgical planning ensures their technical documentation comprehensively details their risk management procedures, including identified risks, mitigation strategies, and residual risk assessment.
- A company providing an AI system for chronic disease management includes evidence of data governance, data labelling processes, and the methodology used for testing the system's accuracy and robustness within its Annex IV documentation.
- •Treating Annex IV as boilerplate. Notified bodies specifically probe training-data provenance and labelling processes.
Frequently asked questions
Related terms
Grouped by themeEditor's picks
· Hand-selected related conceptsFor AI-enabled medical devices, AI Act requirements are assessed through the MDR/IVDR notified-body procedure, not a separate CE route.
AI systems captured by Article 6 of the EU AI Act because they are safety components of regulated products or listed in Annex III.
The dossier of design, manufacturing, risk, and clinical/performance evidence a manufacturer compiles under MDR/IVDR Annexes II and III to demonstrate conformity.
More in Regulatory
· Same categoryFDA submission demonstrating a device is substantially equivalent to a legally marketed predicate.
Two alternative disclosure mechanisms in a 510(k) submission, a Summary is public on FDA's website; a Statement promises to share Safety & Effectiveness info on request.
Formal mechanism to ask FDA whether a product is a device and, if so, its likely classification.
510(k) variant that relies on FDA guidance, special controls, or recognized consensus standards.
Where this term appears across MedTech Terms.
Latest in MedTech
Sources
3 sourcesEvery citation below opens the original document. Each is graded against our source-tier hierarchy so you can see what rests on binding law versus commentary.
- 1Regulation (EU) 2024/1689, Article 11 and Annex IVTier 1 VerifiedEUR-Lexeur-lex.europa.eu
- 2IMDRF DocumentsTier 2 VerifiedIMDRFimdrf.org
- 3RAPS Regulatory FocusTier 4 VerifiedRAPSraps.org
Inline markers like [1] jump to the matching reference above.